Prospective Assessment of Epiduroscopy regarding Diagnostic and Therapeutic Outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030424

Enrollment

Registered

2023-09-25

Start date

2022-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.4

Interventions

Group 1: Day zero: Treatment: Epiduroscopy Post-operaively: Regular Follow-Up (usuallly day 1 postop, day of discharge, ambulatory visit at 6 weeks, 6 months and 1 year): History, clinical examinsatio

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: indication for epiduroscopy lumbar, thoracic or cervical completed pre-operative preparations

Exclusion criteria

Exclusion criteria: no consent

Design outcomes

Primary

Measure	Time frame
Pain (VAS), QOL (SF36), Function (ODI), Complications, Revisions	—

Secondary

Measure	Time frame
Comparison of the primary outcome parameters in relation to baseline	—

Countries

Germany

Contacts

Public ContactSimon Weidert

LMU Klinikum

simon.weidert@med.uni-muenchen.de+498944000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026